{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:56:30Z","timestamp":1792180590143,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T00:00:00Z","timestamp":1574467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T00:00:00Z","timestamp":1574467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1038\/s41386-019-0570-x","type":"journal-article","created":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T11:02:23Z","timestamp":1574506943000},"page":"606-612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression"],"prefix":"10.1038","volume":"45","author":[{"given":"Jennifer L.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhaya","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Hatchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6886-767X","authenticated-orcid":false,"given":"Abigail","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"Birmingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olabisi","family":"Owoeye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Batten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Blier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,23]]},"reference":[{"key":"570_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.4088\/JCP.v66n0401","volume":"66","author":"W Coryell","year":"2005","unstructured":"Coryell W, Young EA. Clinical predictors of suicide in primary major depressive disorder. Clin Psychiatry. 2005;66:412\u201317.","journal-title":"Clin Psychiatry"},{"key":"570_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4088\/JCP.0307e08","volume":"68","author":"AJ Rush","year":"2007","unstructured":"Rush AJ. Limitations in efficacy of antidepressant monotherapy. J Clin Psychiatry. 2007;68:8\u201310.","journal-title":"J Clin Psychiatry"},{"key":"570_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/sltb.12022","volume":"43","author":"PN Pfeiffer","year":"2013","unstructured":"Pfeiffer PN, Hyungjin MK, Ganoczy D, Zivin K, Valenstein M. Treatment-resistant depression and risk of suicide. Suicide Life-Threat Behav. 2013;43:356\u201365.","journal-title":"Suicide Life-Threat Behav"},{"key":"570_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-clinpsy-021815-093204","volume":"12","author":"ED Klonsky","year":"2016","unstructured":"Klonsky ED, May AM, Saffer BY. Suicide, suicide attempts, and suicidal ideation. Annu Rev Clin Psychol. 2016;12:307\u201330.","journal-title":"Annu Rev Clin Psychol"},{"key":"570_CR5","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.1016\/j.amepre.2014.06.012","volume":"47","author":"JJ Griffiths","year":"2014","unstructured":"Griffiths JJ, Zarate CA Jr, Rasimas JJ. Existing and novel biological therapeutics in suicide prevention.Am J Prev Med. 2014;47:S195\u2013203.","journal-title":"Am J Prev Med"},{"key":"570_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","volume":"74","author":"G Sanacora","year":"2017","unstructured":"Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, et al. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry. 2017;74:399\u2013405.","journal-title":"JAMA Psychiatry"},{"key":"570_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","volume":"175","author":"ST Wilkinson","year":"2018","unstructured":"Wilkinson ST, Ballard ED, Bloch MH, Mathew SJ, Murrough JW, Feder A, et al. The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis. Am J Psychiatry. 2018;175:150\u201358.","journal-title":"Am J Psychiatry"},{"key":"570_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuron.2019.09.034","volume":"104","author":"A Holtz","year":"2019","unstructured":"Holtz A, M\u00fclsch F, Schwarz MK, Hollmann M, D\u00f6br\u00f6ssy MD, Coenen VA, et al. Enhanced mGlu5 signaling in excitatory neurons promotes rapid antidepressant effects via AMPA receptor activation. Neuron. 2019;104:1\u201315.","journal-title":"Neuron"},{"key":"570_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jpsychires.2014.07.027","volume":"58","author":"ED Ballard","year":"2014","unstructured":"Ballard ED, Ionescu DF, Vande Voort JL, Niciu MJ, Richards EM, Luckenbaugh DA, et al. Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. J Psychiatr Res. 2014;58:161\u201366.","journal-title":"J Psychiatr Res"},{"key":"570_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/da.22253","volume":"31","author":"RB Price","year":"2014","unstructured":"Price RB, Iosifescu DV, Murrough JW, Chang LC, Al Jurdi RK, Iqbal SZ, et al. Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Depress Anxiety. 2014;31:335\u201343.","journal-title":"Depress Anxiety"},{"key":"570_CR11","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.4088\/JCP.15m10440","volume":"78","author":"JL Vande Voort","year":"2017","unstructured":"Vande Voort JL, Ballard ED, Luckenbaugh DA, Bernert RA, Richards EM, Niciu MJ, et al. Antisuicidal response following ketamine infusion is associated with decreased nighttime wakefulness in major depressive disorder and bipolar disorder. J Clin Psychiatry. 2017;78:1068\u201374.","journal-title":"J Clin Psychiatry"},{"key":"570_CR12","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","volume":"71","author":"CA Zarate Jr","year":"2012","unstructured":"Zarate CA Jr, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A, et al. Replication of ketamine\u2019s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry. 2012;71:939\u201346.","journal-title":"Biol Psychiatry"},{"key":"570_CR13","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4088\/JCP.09m05327blu","volume":"71","author":"N DiazGranados","year":"2010","unstructured":"DiazGranados N, Ibrahim LA, Brutsche NE, Ameli R, Henter ID, Luckenbaugh DA, et al. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry. 2010;71:1605\u201311.","journal-title":"J Clin Psychiatry"},{"key":"570_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1176\/appi.ajp.2017.17060647","volume":"175","author":"MF Grunenbaum","year":"2018","unstructured":"Grunenbaum MF, Galfalvy HC, Choo TH, Keilp JG, Moitra VK, Parris MS, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175:327\u201335.","journal-title":"Am J Psychiatry"},{"key":"570_CR15","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1017\/S0033291715001506","volume":"45","author":"JW Murrough","year":"2015","unstructured":"Murrough JW, Soleimani L, DeWilde KE, Collins KA, Lapidus KA, Iacoviello BM, et al. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Psychol Med. 2015;45:3571\u201380.","journal-title":"Psychol Med"},{"key":"570_CR16","doi-asserted-by":"publisher","first-page":"e719","DOI":"10.4088\/JCP.15m10056","volume":"77","author":"DF Ionescu","year":"2016","unstructured":"Ionescu DF, Swee MB, Pavone KJ, Taylor N, Akeju O, Baer L, et al. Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study. J Clin Psychiatry. 2016;77:e719\u201325.","journal-title":"J Clin Psychiatry"},{"key":"570_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jad.2016.09.008","volume":"206","author":"JL Vande Voort","year":"2016","unstructured":"Vande Voort JL, Morgan RJ, Kung S, Rasmussen KG, Rico J, Palmer BA, et al. Continuation phase intravenous ketamine in adults with treatment-resistant depression. J Affect Disord. 2016;206:300\u20134.","journal-title":"J Affect Disord"},{"key":"570_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jpsychires.2018.09.013","volume":"106","author":"W Zheng","year":"2018","unstructured":"Zheng W, Zhou Y-L, Liu W-J, Wang C-Y, Zhan Y-N, Li H-Q, et al. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression. J Psychiatr Res. 2018;106:61\u20138.","journal-title":"J Psychiatr Res"},{"key":"570_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","volume":"176","author":"JL Phillips","year":"2019","unstructured":"Phillips JL, Norris S, Talbot J, Birmingham M, Hatchard T, Ortiz A, et al. Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial. Am J Psychiatry. 2019;176:401\u20139.","journal-title":"Am J Psychiatry"},{"key":"570_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jad.2018.07.077","volume":"241","author":"ED Ballard","year":"2018","unstructured":"Ballard ED, Yarrington JS, Farmer CA, Richards E, Machado-Vieira R, Kadriu B, et al. Characterizing the course of suicidal ideation response to ketamine. J Affect Disord. 2018;241:86\u201393.","journal-title":"J Affect Disord"},{"key":"570_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jad.2019.03.071","volume":"251","author":"Z Yanni","year":"2019","unstructured":"Yanni Z, Bin Z, Yanling Z, Wei Z, Weijian L, Chengyu W, et al. A preliminary study of anti-suicidal efficacy of repeated ketamine infusions in depression with suicidal ideation. J Affect Disord. 2019;251:205\u201312.","journal-title":"J Affect Disord"},{"key":"570_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","volume":"74","author":"JW Murrough","year":"2013","unstructured":"Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, et al. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry. 2013;74:250\u20136.","journal-title":"Biol Psychiatry"},{"key":"570_CR23","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000."},{"issue":"Suppl 20","key":"570_CR24","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22\u201333.","journal-title":"J Clin Psychiatry"},{"key":"570_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, \u00c5sberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382\u20139.","journal-title":"Br J Psychiatry"},{"issue":"Suppl 16","key":"570_CR26","first-page":"10","volume":"62","author":"HA Sackeim","year":"2001","unstructured":"Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 2001;62(Suppl 16):10\u20137.","journal-title":"J Clin Psychiatry"},{"key":"570_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/JCP.0000000000000316","volume":"35","author":"MA Frye","year":"2015","unstructured":"Frye MA, Blier P, Tye SJ. Concomitant benzodiazepine use attenuates ketamine response: implications for large scale study design and clinical development. J Clin Psychopharmacol. 2015;35:334\u20136.","journal-title":"J Clin Psychopharmacol"},{"key":"570_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","volume":"54","author":"AJ Rush","year":"2003","unstructured":"Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54:573\u201383.","journal-title":"Biol Psychiatry"},{"key":"570_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jpsychires.2015.06.003","volume":"68","author":"ED Ballard","year":"2015","unstructured":"Ballard ED, Luckenbaugh DA, Richards EM, Walls TL, Brutsch\u00e9 NE, Ameli R, et al. Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant. J Psychiatr Res. 2015;68:68\u201373.","journal-title":"J Psychiatr Res"},{"key":"570_CR30","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","volume":"19","author":"H Akaike","year":"1974","unstructured":"Akaike H. A new look at the statistical model identification. IEEE Trans Autom Contr. 1974;19:716\u201323.","journal-title":"IEEE Trans Autom Contr"},{"key":"570_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","volume":"67","author":"M aan het Rot","year":"2010","unstructured":"aan het Rot M, Collins KA, Murrough JW, Perez AM, Reich DL, Charney DS, et al. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry. 2010;67:139\u201345.","journal-title":"Biol Psychiatry"},{"key":"570_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jad.2018.07.073","volume":"241","author":"M Sinyor","year":"2018","unstructured":"Sinyor M, Williams M, Belo S, Orser B, Vincent M, Mah L, et al. Ketamine augmentation for major depressive disorder and suicidal ideation: preliminary experience in an inpatient psychiatry setting. J Affect Disord. 2018;241:103\u20139.","journal-title":"J Affect Disord"},{"key":"570_CR33","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jad.2018.09.037","volume":"243","author":"DF Ionescu","year":"2019","unstructured":"Ionescu DF, Bentley KH, Eikermann M, Taylor N, Akeju O, Swee MB, et al. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: a randomized, double blind, placebo controlled trial. J Affect Disord. 2019;243:516\u201324.","journal-title":"J Affect Disord"},{"key":"570_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/0004867416631828","volume":"51","author":"C Cusin","year":"2017","unstructured":"Cusin C, Ionescu DF, Pavone KJ, Akeju O, Cassano P, Taylor N, et al. Ketamine augmentation for outpatients with treatment-resistant depression: preliminary evidence for two-step intravenous dose escalation. Aust N. Z J Psychiatry. 2017;51:55\u201364.","journal-title":"Aust N. Z J Psychiatry"},{"key":"570_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","volume":"71","author":"A Feder","year":"2014","unstructured":"Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71:681\u20138.","journal-title":"JAMA Psychiatry"},{"key":"570_CR36","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.7205\/MILMED-D-15-00431","volume":"181","author":"J Burger","year":"2016","unstructured":"Burger J, Capobianco M, Lovern R, Boche B, Ross E, Darracq MA, et al. A double-blinded, randomized, placebo-controlled sub-dissociative dose ketamine pilot study in the treatment of acute depression and suicidality in a military emergency department setting. Mil Med. 2016;181:1195\u20139.","journal-title":"Mil Med"},{"key":"570_CR37","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.18632\/oncotarget.13743","volume":"8","author":"W Fan","year":"2017","unstructured":"Fan W, Yang H, Sun Y, Zhang J, Li G, Zheng Y, et al. Ketamine rapidly relieves acute suicidal ideation in cancer patients: a randomized controlled clinical trial. Oncotarget. 2017;8:2356\u201360.","journal-title":"Oncotarget"},{"key":"570_CR38","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","volume":"168","author":"K Posner","year":"2011","unstructured":"Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168:1266\u201377.","journal-title":"Am J Psychiatry"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-019-0570-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-019-0570-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-019-0570-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:07:38Z","timestamp":1684602458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-019-0570-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,23]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["570"],"URL":"https:\/\/doi.org\/10.1038\/s41386-019-0570-x","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,23]]},"assertion":[{"value":"12 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}